The emerging link between nutrition, inflammation and atherosclerosis

Expert Review of Cardiovascular Therapy

Volumn 4, Issue 3, 2006, Pages 385-393

  Paoletti, Rodolfo ^a   Poli, Andrea ^b   Cignarella, Andrea ^a,c  

^a UNIVERSITY OF MILAN   (Italy)

^b Nutrition Foundation of Italy   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

Alcohol consumption; Glycemic index; Inflammation; Mediterranean diet; Metabolic syndrome; Omega 3 fatty acids; Saturated fatty acids

Indexed keywords

3 HYDROXYBUTYRIC ACID; ANTILIPEMIC AGENT; ANTIOXIDANT; ARGININE; C REACTIVE PROTEIN; DOCOSAHEXAENOIC ACID; EZETIMIBE; FATTY ACID DERIVATIVE; FIBRIC ACID DERIVATIVE; FISH OIL; FOLIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSAPENTAENOIC ACID; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; ISOPRENALINE; LINOLENIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; POLYUNSATURATED FATTY ACID; PRAVASTATIN; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ALCOHOL CONSUMPTION; ANTIARRHYTHMIC ACTIVITY; ANTICOAGULATION; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; CALORIC RESTRICTION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CLINICAL STUDY; CLINICAL TRIAL; DIETARY INTAKE; DISEASE ASSOCIATION; DRUG RECEPTOR BINDING; FAT INTAKE; HIGH FIBER DIET; HUMAN; HYPERCHOLESTEROLEMIA; INFLAMMATION; MEDICAL RESEARCH; METABOLIC SYNDROME X; MOLECULAR MECHANICS; NONHUMAN; NUTRIENT; NUTRITION; REVIEW; TREATMENT OUTCOME; WEIGHT REDUCTION;

ALCOHOL DRINKING; ATHEROSCLEROSIS; CALORIC RESTRICTION; DIET; FATTY ACIDS; FATTY ACIDS, OMEGA-3; GLYCEMIC INDEX; HUMANS; INFLAMMATION; METABOLIC SYNDROME X; NUTRITION PHYSIOLOGY;

EID: 33744473302     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.4.3.385     Document Type: Review

References (61)

1. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 105, 1135-1143 (2002).
2. Kesteloot H. Alcohol intake and markers of inflammation. Eur. Heart J. 25, 2075-2076 (2004).
3. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation 107, 391-397 (2003).
4. Ridker PM, Cannon CP, Morrow D et al. C-reactive protein levels and outcomes after statin therapy. N. Engl. J. Med. 352, 20-28 (2005).
5. Nissen SE, Tuzcu EM, Schoenhagen P et al. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N. Engl. J. Med. 352, 29-38 (2005).
6. Albert MA, Danielson E, Rifai N, Ridker PM; for the PRINCE Investigators. Effect of statin therapy on C-reactive protein levels - the Pravastatin Inflammation/CRP Evaluation (PRINCE): a randomized trial and cohort study. JAMA 286, 64-70 (2001).
7. Chrysohoou C, Panagiotakos DB, Pitsavos C, Das UN, Stefanadis C. Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: the ATTICA Study. J. Am. Coll. Cardiol. 44, 152-158 (2004).
8. Gao X, Bermudez OI, Tucker KL. Plasma C-reactive protein and homocysteine concentrations are related to frequent fruit and vegetable intake in Hispanic and non-Hispanic white elders. J. Nutr. 134, 913-918 (2004).
9. Jula A, Marniemi J, Huupponen R, Virtanen A, Rastas M, Rönnemaa T. Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men: a randomized controlled trial. JAMA 287, 598-605 (2002).
10. Kris-Etherton PM, Lichtenstein AH, Howard BV, Steinberg D, Witztum JL. Antioxidant vitamin supplements and cardiovascular disease. Circulation 110, 637-641 (2004).
11. Esposito K, Marfella R, Ciotola M et al. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 292, 1440-1446 (2004).
12. Nantel G. Glycemic carbohydrate: an international perspective. Nutr. Rev. 61, S34-S39 (2003).
13. Granfeldt Y, Bjorck I, Hagander B. On the importance of processing conditions, product thickness and egg addition for the glycaemic and hormonal responses to pasta: a comparison with bread made from 'pasta ingredients.' Eur. J. Clin. Nutr. 45, 489-499 (1991).
14. Pereira MA, Swain J, Goldfine AB, Rifai N, Ludwig DS. Effects of a low-glycemic load diet on resting energy expenditure and heart disease risk factors during weight loss. JAMA 292, 2482-2490 (2004).
15. Esposito K, Nappo F, Marfella R et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 106, 2067-2077 (2002).
16. Pawlak DB, Kushner JA, Ludwig DS. Effects of dietary glycaemic index on adiposity, glucose homoeostasis, and plasma lipids in animals. Lancet 364, 778-785 (2004).
17. Pereira MA, O'Reilly E, Augustsson K et al. Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Arch. Intern. Med. 164, 370-376 (2004).
18. King DE, Egan BM, Geesey ME. Relation of dietary fat and fiber to elevation of C-reactive protein. Am. J. Cardiol. 92, 1335-1339 (2003).
19. Albert MA, Glynn RJ, Ridker PM. Alcohol consumption and plasma concentration of C-reactive protein. Circulation 107, 443-447 (2003).
20. Imhof A, Froelich M, Brenner H, Boeing H, Pepys MB, Koenig W. Effect of alcohol consumption on systemic markers of inflammation. Lancet 357, 763-767 (2001).
21. Volpato, S, Pahor M, Ferrucci L et al. Relationship of alcohol intake with inflammatory markers and plasminogen activator inhibitor-1 in well-functioning older adults: the Health, Aging, and Body Composition study. Circulation 109, 607-612 (2004).
22. Imhof A, Woodward M, Doering A et al. Overall alcohol intake, beer, wine, and systemic markers of inflammation in western Europe: results from three MONICA samples (Augsburg, Glasgow, Lille). Eur. Heart J. 25, 2092-2100 (2004).
23. van der Gaag MS, van Tol A, Vermunt SH, Scheek LM, Schaafsma G, Hendriks HF. Alcohol consumption stimulates early steps in reverse cholesterol transport. J. Lipid Res. 42, 2077-2083 (2001).
24. Goldberg IJ, Mosca L, Piano MR, Fisher EA. Wine and your heart - a science advisory for healthcare professionals from the Nutrition Committee, Council on Epidemiology and Prevention, and Council on Cardiovascular Nursing of the American Heart Association. Cirrulation 103, 472-475 (2001).
25. Retterstol L, Berge KE, Braaten O, Eikvar L, Pedersen TR, Sandvik L. A daily glass of red wine: does it affect markers of inflammation? Alcohol 40, 102-105 (2005).
26. Williams MJ, Sutherland WH, Whelan AP, McCormick MP, de Jong SA. Acute effect of drinking red and white wines on circulating levels of inflammation-sensitive molecules in men with coronary artery disease. Metabolism 53, 318-323 (2004).
27. Teragawa H, Fukuda Y, Matsuda K et al. Effect of alcohol consumption on endothelial function in men with coronary artery disease. Atherosclerosis 165, 145-152 (2002).
28. Zureik M, Gariepy J, Courbon D et al. Alcohol consumption and carotid artery structure in older French adults: the Three-City Study. Stroke 35, 2770-2775 (2004).
29. Facchini F, Chen YD, Reaven GM. Light-to-moderate alcohol intake is associated with enhanced insulin sensitivity. Diabetes Care 17, 115-119 (1994).
30. Laaksonen DE, Nyyssonen K, Niskanen L, Rissanen TH, Salonen JT. Prediction of cardiovascular mortality in middle-aged men by dietary and serum linoleic and polyunsaturated fatty acids. Arch. Intern, Med. 165, 193-199 (2005).
31. Howard BV, Van Horn L, Hsia J et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative randomized controlled Dietary Modification Trial. JAMA 295, 655-666 (2006).
32. Zock PL, Katan MB. Trans fatty acids, lipoproteins, and coronary risk. Can. J. Physiol. Pharmacol. 75, 211-216 (1997).
33. Mozaffarian D, Pischon T, Hankinson SE et al. Dietary intake of trans fatty acids and systemic inflammation in women. Am. J. Clin. Nutr. 79, 606-612 (2004).
34. Lopez-Garcia E, Schulze MB, Meigs JB et al. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J. Nutr. 135, 562-566 (2005).
35. Baer DJ, Judd JT, Clevidence BA, Tracy RP. Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am. J. Clin. Nutr. 79, 969-973 (2004).
36. Keogh JB, Grieger JA, Noakes M, Clifton PM. Flow-mediated dilatation is impaired by a high-saturated fat diet but not by a high-carbohydrate diet. Arterioscler. Thromb. Vasc. Biol. 25, 1274-1279 (2005).
37. de Roos NM, Bots ML, Katan MB. Replacement of dietary saturated fatty acids by trans fatty acids lowers serum HDL cholesterol and impairs endothelial function in healthy men and women. Arterioscler. Thromb. Vasc. Biol. 21, 1233-1237 (2001).
38. Lin J, Yang R, Tarr PT et al. Hyperlipidemic effects of dietary saturated fats mediated through PGC-1β coactivation of SREBP. Cell 120, 261-273 (2005).
39. Daviglus ML, Stamler J, Orencia AJ et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N. Engl. J. Med. 336, 1046-1053 (1997).
40. Wang C, Chung M, Lichtenstein A et al. Effects of omega-3 fatty acids on cardiovascular disease - summary, evidence report/technology assessment. Evid. Rep. Technol. Assess. 94, 1-8 (2004).
41. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354, 447-455 (1999).
42. Marchioli R, Barzi F, Bomba E et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-Prevenzione. Circulation 105, 1897-1903 (2002).
43. Kratz M, Gulbahce E, von Eckardstein A et al. Dietary mono- and polyunsaturated fatty acids similarly affect LDL size in healthy men and women. J. Nutr. 132, 715-718 (2002).
44. Vega-Lopez S, Kaul N, Devaraj S, Cai RY, German B, Jialal I. Supplementation with ω3 polyunsaturated fatty acids and all-rac α-tocopherol alone and in combination failed to exert an anti-inflammatory effect in human volunteers. Metabolism 53, 236-240 (2004).
45. Zhao G, Etherton TD, Martin KR, West SG, Gillies PJ, Kris-Etherton PM. Dietary α-linolenic acid reduces inflammatory and lipid cardiovascular risk factors in hypercholesterolemic men and women. J. Nutr. 134, 2991-2997 (2004).
46. Goode GK, Garcia S, Heagerty AM. Dietary supplementation with marine fish oil improves in vitro small artery endothelial function in hypercholesterolemic patients: a double-blind placebo-controlled study. Circulation 96, 2802-2807 (1997).
47. de Lorgeril M, Salen P, Guiraud A, Zeghichi S, Boucher F, de Leiris J. Lipid-lowering drugs and essential omega-6 and omega-3 fatty acids in patients with coronary heart disease. Nutr. Metab. Cardiovase. Dis. 15, 36-41 (2005).
48. Risè P, Pazzucconi F, Sirtori CR, Galli C. Statins enhance arachidonic acid synthesis in hypercholesterolemic patients. Nutr. Metab. Cardiovasc. Dis. 11, 88-94 (2001).
49. Albert CM, Gaziano JM, Willett WC, Manson JE. Nut consumption and decreased risk of sudden cardiac death in the Physicians' Health Study. Arch. Intern. Med. 162, 1382-1387 (2002).
50. Ros E, Nunez I, Perez-Heras A et al. A walnut diet improves endothelial function in hypercholesterolemic subjects: a randomized crossover trial. Circulation 109, 1609-1614 (2004).
51. Jenkins DJ, Kendall CW, Marchie A et al. Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA 290, 502-510 (2003).
52. Jenkins DJ, Kendall CW, Marchie A et al. Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants. Am. J. Clin. Nutr. 81, 380-387 (2005).
53. Jenkins DJ, Kendall CW, Marchie A et al. Direct comparison of dietary portfolio vs statin on C-reactive protein. Eur. J. Clin. Nutr. 59, 851-860 (2005).
54. Jenkins DJ, Kendall CW, Faulkner DA et al. Assessment of the longer-term effects of a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia. Am. J. Clin. Nutr. 83, 582-591 (2006).
55. Heilbronn LK, Noakes M, Clifton PM. Energy restriction and weight loss on verylow-fat diets reduce C-reactive protein concentrations in obese, healthy women. Arterioscler. Thromb. Vasc. Biol. 21, 968-970 (2001).
56. Lamarche B, Desroches S, Archer WR et al. C-reactive protein levels predict the lipid and lipoprotein response to dietary interventions. Presented at the 2nd International Symposium on Triglycerides and HDL - role in cardiovascular disease and the metabolic syndrome, New York, NY, USA (2005).
57. Williams PT, Blanche PJ, Rawlings R, Krauss RM. Concordant lipoprotein and weight responses to dietary fat change in identical twins with divergent exercise levels. Am. J. Clin. Nutr. 82, 181-187 (2005).
58. Levantesi G, Macchia A, Marfisi R et al. Metabolic syndrome and risk of cardiovascular events after myocardial infarction. J. Am. Coll. Cardiol. 46, 277-283 (2005).
59. Moore LL, Visioni AJ, Qureshi MM, Bradlee ML, Ellison RC, D'Agostino R. Weight loss in overweight adults and the long-term risk of hypertension: the Framingham study. Arch. Intern. Med. 165, 1298-1303 (2005).
60. Corton JC, Apte U, Anderson SP et al. Mimetics of caloric restriction include agonists of lipid-activated nuclear receptors. J. Biol. Chem. 279, 46204-46212 (2004).
61. Taggart AK, Kero J, Gan X et al. (D) - β-hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. J. Biol. Chem. 280, 26649-26652 (2005).